Literature DB >> 32464272

Uganda's First 100 COVID-19 Cases: Trends and Lessons.

Ronald Olum1, Felix Bongomin2.   

Abstract

Entities:  

Year:  2020        PMID: 32464272      PMCID: PMC7247991          DOI: 10.1016/j.ijid.2020.05.073

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


× No keyword cloud information.
Coronavirus disease -2019 (COVID-19) continues to hit-hard on many countries across the world. Uganda reported its first case of COVID-19 on the March 21, 2020 (Coronavirus Disease, 2020). A 36-year-old businessman from Kampala, Uganda’s capital, who had travelled to Dubai, United Arab Emirates (UAE) in a healthy condition four days prior to his return. He presented with fever and flu-like symptoms at Entebbe International Airport (EIA) and his sample tested positive for SARS-CoV-2, the causative agent of COVID-19 (Coronavirus Disease, 2020). Consequently, individuals who had been to UAE two weeks prior to the first case were traced by Ministry of Health (MoH) Uganda and subjected to institutional quarantine. In the following two weeks (March 21 to April 5), there was a rapid rise in the number of cases to 52, most of whom were imported cases from institutional quarantine, Figure 1 . The epidemiologic curve had flattened between April 5 to April 19. However, we observed a second upsurge in incident cases during the late April and early May ultimately reaching 100 cases on May 6, 2020, Figure 1 (Ministry of Health Uganda, 2020). Of these, 89 cases (89%) were imported, 8 (8%) local transmissions and 3 (3%) with unknown chain of transmission. Majority of the cases were truck drivers (40, 40%) from Kenya (21) and Tanzania (14) with 3 Ugandans, 1 Eritrean and 1 Burundian. The truck drivers transit through Uganda, carrying cargo to or from neighbouring countries who have all recorded rises in cases of late (Worldometer, 2020). In addition to the truck drivers, two cases of local transmission have been reported among Uganda Police Force officers, which may indicate an on-going community transmission of COVID-19.
Figure 1

Cumulative COVID-19 cases in Uganda (Source: Ministry of Health Uganda. COVID-19 Information Portal (Ministry of Health Uganda, 2020)).

Cumulative COVID-19 cases in Uganda (Source: Ministry of Health Uganda. COVID-19 Information Portal (Ministry of Health Uganda, 2020)). Uganda has to date largely been able to achieve control of local transmission through lockdown, massive testing of people in quarantine, country’s borders and their contacts in addition to public health campaigns. Testing of truck drivers at the borders commenced on April 10th, 2020. MoH Uganda also commissioned community testing to establish the status of local transmission on the April 28, 2020. As of 7th May 2020, 55 cases have recovered and have been discharged home, 45 are receiving treatment and no recorded deaths. Whereas Uganda is in a lockdown with no public and private transport allowed, cargo planes and trucks have been allowed to move. Of great threat are truck drivers who have rest points (lodges, eating places and fuel stations) along the journey and interact with a number of local Ugandans. MoH-Uganda has put measures like testing drivers at all border points but they are left to continue with the journey until pronounced positive, tracked and taken to treatment centres. Hospitality staffs and security personnel along these routes are at a high risk of infection. It is of immense importance that all the East African countries work together to ensure there are no contact between these drivers and the community; and if unavoidable, preventive measures prescribed by WHO are put in place. In addition, introduction of rapid point of care testing cannot be overemphasized, especially at the border points to reduce the long turnaround time and guide decision making.

Funding source

There was no funding received from any individual or organisation.

Ethical approval

No ethical approval required by Uganda National Council for Science and Technology.

Conflict of interests

The authors declare no conflict of interests.

Declaration of interests

None.
  12 in total

1.  Lived experiences of frontline healthcare providers offering maternal and newborn services amidst the novel corona virus disease 19 pandemic in Uganda: A qualitative study.

Authors:  Herbert Kayiga; Diane Achanda Genevive; Pauline Mary Amuge; Andrew Sentoogo Ssemata; Racheal Samantha Nanzira; Annettee Nakimuli
Journal:  PLoS One       Date:  2021-12-10       Impact factor: 3.240

2.  Global influenza surveillance systems to detect the spread of influenza-negative influenza-like illness during the COVID-19 pandemic: Time series outlier analyses from 2015-2020.

Authors:  Natalie L Cobb; Sigrid Collier; Engi F Attia; Orvalho Augusto; T Eoin West; Bradley H Wagenaar
Journal:  PLoS Med       Date:  2022-07-19       Impact factor: 11.613

3.  Commentary: Factors Associated With Mortality Among the COVID-19 Patients Treated at Gulu Regional Referral Hospital.

Authors:  Ronald Olum; Joseph Baruch Baluku
Journal:  Front Public Health       Date:  2022-07-05

4.  Facility-Level Approaches for COVID-19 When Caseload Surpasses Surge Capacity.

Authors:  David A Walton; Louise C Ivers
Journal:  Am J Trop Med Hyg       Date:  2020-06-26       Impact factor: 2.345

5.  Public health challenges posed by delays in obtaining COVID-19 clearance for long-distance truckers across East Africa.

Authors:  John Gachohi; Jane Aduda; Reuben Thuo; Joseph Mung'atu; Fred Wamunyokoli; Thomas Ngigi; Henry Athiany; Gideon Kikuvi; Susan Mambo; Wairimu Gichaiya; Joseph Matheri; Patrick Mburugu; Justus Simba; Carol Otiwa; Charles Muriuki; Joshua Mwaura; May Yariwo; Beatrice Kariuki; Joseph Machua; Catherine Mwangi; Patrick Amoth; Rashid Aman; Onesmus Kamau; Kennedy Muthoka; Jacob Otieno; Pascal Mwele; Rose Nzioka; Simon Karanja
Journal:  Glob Epidemiol       Date:  2020-10-24

6.  Assessing Knowledge, Attitudes and Practices Towards COVID-19 Public Health Preventive Measures Among Patients at Mulago National Referral Hospital.

Authors:  Nelson Twinamasiko; Ronald Olum; Anna Maria Gwokyalya; Innocent Nakityo; Enock Wasswa; Emmanuel Sserunjogi
Journal:  Risk Manag Healthc Policy       Date:  2021-01-20

7.  High Mortality During the Second Wave of the Coronavirus Disease 2019 (COVID-19) Pandemic in Uganda: Experience From a National Referral COVID-19 Treatment Unit.

Authors:  Felix Bongomin; Brian Fleischer; Ronald Olum; Barbra Natukunda; Sarah Kiguli; Pauline Byakika-Kibwika; Joseph Baruch Baluku; Frederick Nelson Nakwagala
Journal:  Open Forum Infect Dis       Date:  2021-11-18       Impact factor: 3.835

8.  Depression, anxiety, and stress among Ugandan university students during the COVID-19 lockdown: an online survey.

Authors:  Sarah Maria Najjuka; Gaudencia Checkwech; Ronald Olum; Scholastic Ashaba; Mark Mohan Kaggwa
Journal:  Afr Health Sci       Date:  2021-12       Impact factor: 0.927

9.  Suicidal behaviours among Ugandan university students: a cross-sectional study.

Authors:  Mark Mohan Kaggwa; Innocent Arinaitwe; Moses Muwanguzi; Elicana Nduhuura; Jonathan Kajjimu; Moses Kule; Sarah Maria Najjuka; Rahel Nkola; Noble Ajuna; Nicholas Kisaakye Wamala; Ivan Machacha; Mohammed A Mamun; Cyrus Su-Hui Ho; Mark D Griffiths; Godfrey Zari Rukundo
Journal:  BMC Psychiatry       Date:  2022-04-01       Impact factor: 3.630

10.  Feasibility of collecting and processing of COVID-19 convalescent plasma for treatment of COVID-19 in Uganda.

Authors:  Winters Muttamba; John Lusiba; Loryndah Olive Namakula; Pauline Byakika-Kibwika; Francis Ssali; Henry Ddungu; Levicatus Mugenyi; Noah Kiwanuka; Rogers Sekibira; Cissy Kityo; Dorothy Keyune; Susan Acana; Ambrose Musinguzi; Ayub Masasi; Joseph Byamugisha; David Mpanju; Walter Jack Musoki; Hellen Aanyu Tukamuhebwa; Fred Nakwagala; Bernard Sentalo Bagaya; Alex Kayongo; Ivan Kimuli; Rebecca Nantanda; Winceslaus Katagira; Esther Buregyeya; Rosemary Byanyima; Baterana Byarugaba; Trishul Siddharthan; Henry Mwebesa; Olaro Charles; Moses Lutaakome Joloba; William Bazeyo; Bruce Kirenga
Journal:  PLoS One       Date:  2021-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.